Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis
Peng Liu, Yerong Qian, Xin Liu, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 20

Showing 20 citing articles:

Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials
Wei‐Chen Huang, Yuan Li, Pin-Xuan Chen, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Current Status and Prospect of Delivery Vehicle Based on Mesenchymal Stem Cell-Derived Exosomes in Liver Diseases
Xinfeng Lu, Haijun Guo, Xuyong Wei, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 2873-2890
Open Access | Times Cited: 24
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease
Shulin Wei, Mingxing Li, Qin Wang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3307-3334
Open Access | Times Cited: 7
Arctium lappa L. polysaccharides enhanced the therapeutic effects of nasal ectomesenchymal stem cells against liver fibrosis by inhibiting the Wnt/β-catenin pathway
Wen Xiang, Guoliang Yin, Haoming Liu, et al.
International Journal of Biological Macromolecules (2024) Vol. 261, pp. 129670-129670
Closed Access | Times Cited: 5
Fucoxanthin Enhances the Antifibrotic Potential of Placenta-derived Mesenchymal Stem Cells in a CCl4-induced Mouse Model of Liver
Vasilii N. Slautin, Konstantin Konyshev, I. V. Gavrilov, et al.
Current Stem Cell Research & Therapy (2024) Vol. 19, Iss. 11, pp. 1484-1496
Closed Access | Times Cited: 4
Adipose Tissue and Umbilical Cord Tissue: Potential Sources of Mesenchymal Stem Cells for Liver Fibrosis Treatment
Hafiz Ghufran, Maryam Azam, Azra Mehmood, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 14, Iss. 4, pp. 101364-101364
Closed Access | Times Cited: 4
Natural small molecules synergize mesenchymal stem cells for injury repair in vital organs: a comprehensive review
Y. H. Qu, Zhe Wang, Lingjuan Dong, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes
Manar A. Didamoony, Ayman A. Soubh, Lamiaa A. Ahmed
Drug Delivery and Translational Research (2025)
Open Access
Bioreactor-based stem cell therapy for liver fibrosis
Mengchao Yan, Jia Yao, Ye Xie, et al.
Biofabrication (2024) Vol. 16, Iss. 2, pp. 025028-025028
Open Access | Times Cited: 2
Wound healing potential of Cystoseira/mesenchymal stem cells in immunosuppressed rats supported by overwhelming immuno-inflammatory crosstalk
Eman Maher Zahran, Reham H. Mohyeldin, Fatma Mohamed Abd El‐Mordy, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0300543-e0300543
Open Access | Times Cited: 2
Novel insights into the role of immunomodulatory extracellular vesicles in the pathogenesis of liver fibrosis
Jiaxuan Li, Yue Yuan, Qinggang Fu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Mesenchymal stem cell therapy for liver fibrosis need “partner”: Results based on a meta-analysis of preclinical studies
Yan Xu, Xuesong Wang, Xiaolei Zhou, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 32, pp. 3766-3782
Open Access | Times Cited: 1
Wharton's Jelly mesenchymal stem cell‐derived extracellular vesicles induce liver fibrosis‐resolving phenotype in alternatively activated macrophages
Shukoofeh Torabi, Morteza Zarrabi, Faezeh Shekari, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 18
Open Access | Times Cited: 1
Cell therapy for end-stage liver disease: Current state and clinical challenge
Lin Zhang, Youbin Deng, Xue‐Song Bai, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 1
The therapeutic effect and mechanism of CXCL9-overexpressed umbilical cord mesenchymal stem cells on liver fibrosis
Yang Li, Xueqian Zhang, Guiyu Liu, et al.
Research Square (Research Square) (2024)
Open Access
Alcohol-induced hepatic fibrosis and the relation between Hepcidin and liver fibrosis
Al-Shimaa A. Ali, Nora M. Aborehab, Samy M. Saleh, et al.
Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences (2024) Vol. 8, Iss. 1, pp. 37-44
Open Access
Sequential system based on ferritin delivery system and cell therapy for modulating the pathological microenvironment and promoting recovery
Lixing Xu, Jie Yang, Xinyu Cao, et al.
International Journal of Pharmaceutics (2024) Vol. 664, pp. 124607-124607
Closed Access
The role of ferroptosis-related non-coding RNA in liver fibrosis
Guozhu Zhang, Kejia Wu, Xiaobo Jiang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Mesenchymal stem cells (MSCs)

Radiopaedia.org (2023)
Closed Access | Times Cited: 1
Page 1

Scroll to top